510(k) K170316
K170316 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "ALINITY C GLUCOSE REAGENT KIT, ALINITY C SYSTEM". The FDA issued a decision of Substantially Equivalent on October 19, 2017. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Abbott Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 19, 2017
- Date Received
- February 1, 2017
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hexokinase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type